Dosimetric evaluation of pacemaker exposure during prostate and pelvic/para-aortic node radiotherapy

Document Type

Article

Publication Date

7-1-2026

Abstract

The clinical management of patients with cardiac implantable electronic devices (CIEDs) undergoing radiotherapy is challenging due to the potential risk of radiation-induced device malfunction. This study aims to quantify the out-of-field dose delivered to a pacemaker during three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer, with particular emphasis on comparing localized prostate treatments with extended irradiation involving pelvic and para-aortic lymph nodes. Monte Carlo simulations were performed using the TOPAS software, incorporating a detailed human phantom, a pacemaker model, and radiation-sensitive integrated CMOS circuitry. Eight clinical scenarios were investigated, beginning with prostate-only irradiation using a 10 × 10 cm2 field, followed by extended treatment configurations including pelvic and para-aortic lymph node irradiation with larger field sizes (15 × 15 and 20 × 20 cm2) and progressively reduced distances between the superior field edge and the heart. The effects of photon beam energy, beam collimation, and the number of treatment fields were also examined. The Monte Carlo simulation results demonstrate that treatment scenarios associated with increased scattered radiation generally result in higher absorbed doses to the pacemaker. While beam collimation significantly reduces the dose to the pacemaker, increasing treatment volume, reflected by larger field sizes, leads to higher device exposure. For localized prostate irradiation, the pacemaker dose was found to be negligible, corresponding to approximately 0.02% of the prescribed target dose. In contrast, inclusion of para-aortic lymph nodes increased the pacemaker dose, reaching a maximum of 1.03% of the target dose when the superior field edge was positioned at a distance of 6 cm from the device. In conclusion, although extended para-aortic irradiation increases scattered dose to the thoracic region compared with localized pelvic treatments, the calculated pacemaker doses remain well below the AAPM recommended 2 Gy threshold associated with clinically significant CIED malfunction. The findings suggest that 3D-CRT for prostate cancer, including pelvic and para-aortic lymph node irradiation, can be safely delivered in patients with pacemakers when appropriate treatment planning considerations are applied.

Keywords

Monte Carlo simulation, Pacemaker, Para-aortic node, Prostate cancer, Radiotherapy

Publication Title

Radiation Physics and Chemistry

ISSN

0969-806X

DOI

10.1016/j.radphyschem.2026.113776

Volume

244

Share

COinS